Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/92626
Type: Artigo de periódico
Title: Immunization Consensus For Children And Adolescents With Rheumatic Diseases [consenso De Imunização Para Crianças E Adolescentes Com Doenças Reumatológicas]
Author: Da Silva C.A.A.
Terreri M.T.R.A.
Barbosa C.M.P.L.
Hilario M.O.E.
Pillegi G.C.S.
Ferriani V.P.L.
Aikawa N.E.
Carvalho J.F.
Jesus A.A.
Sallum A.M.E.
Lotito A.P.N.
Liphaus B.L.
Magalhaes C.S.
Len C.A.
Okuda E.M.
Campos L.M.M.
Carvalho L.M.
Ronchezel M.V.
Dos Santos M.C.
Romanelli P.R.S.
Marini R.
Pereira R.M.R.
Sacchetti S.B.
Lotufo S.
Hirschheimer S.M.S.
Robazzi T.C.M.V.
Vecchi A.P.
Moraes A.J.P.
Naka E.N.
Bica B.
Oliveira S.K.F.
Bastos W.A.
Abstract: Incidence of infectious diseases is higher in children and adolescents with rheumatic diseases than in the general population due to disease activity, possible immune deficiency secondary to the disease itself, or the use of immunosuppressive drugs. Vaccination is effective in reducing morbidity and mortality in those patients. The objective of this study was to establish an evidence-based consensus on the efficacy and safety of vaccination in children and adolescents with rheumatic diseases. Passive immunization of patients and guidelines for people who live with immunosuppressed patients were also included. The 32 pediatric rheumatologists of the Rheumatology Department of the Pediatrics Society of São Paulo, (SPSP, from the Portuguese), São Paulo, SP, Brazil, and/or the Commission on Pediatrics Rheumatology of the Brazilian Society of Rheumatology are responsible for this consensus; some of those professionals are involved on research and scientific publications in this field. The words efficacy and/or safety of different vaccines in children and adolescents with rheumatologic diseases were searched in Medline and Scielo data bases from 1966 to March 2009, including reviews, controlled studies, and case reports. The degree of recommendation and the scientific evidence of the studies were classified in four levels for each vaccine. As a rule, inactive and protein components vaccines are safe for patients with rheumatologic diseases, even in the presence of immunosuppressive therapy. However, live attenuated vaccines are, in general, contraindicated for immunosuppressed patients.
Editor: 
Rights: fechado
Identifier DOI: 
Address: http://www.scopus.com/inward/record.url?eid=2-s2.0-72849111344&partnerID=40&md5=41691852b3290964a0cfa4090649fe88
Date Issue: 2009
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
2-s2.0-72849111344.pdf359.75 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.